» Authors » Mohieddin Barzegar

Mohieddin Barzegar

Explore the profile of Mohieddin Barzegar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 38
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Barzegar M, Allahbakhshian Farsan M, Amiri V, Mohammadi S, Shahsavan S, Mirzaeian A, et al.
Iran J Pharm Res . 2021 Aug; 20(1):384-397. PMID: 34400967
In spite of successful initial remission, chemo-resistance and relapse are still concerning points in acute myeloid leukemia (AML) treatment strategies. Multidrug resistance (MDR) appears to be the major contributor of...
2.
Barzegar M, Farsani M, Rafiee M, Amiri V, Parkhihdeh S, Rad F, et al.
Ann Hematol . 2021 Jul; 100(9):2241-2252. PMID: 34236496
The early death, which is more common in acute promyelocytic leukemia (APL) patients rather than other types of acute myelocytic leukemia (AML) highlights the importance of appropriate diagnostic method for...
3.
Rafiee M, Abbasi M, Rafieemehr H, Mirzaeian A, Barzegar M, Amiri V, et al.
Health Sci Rep . 2021 May; 4(2):e282. PMID: 33977164
Background And Aims: As a curative procedure, hematopoietic stemcell transplantation (HSCT) is an approved treatment for many malignant orbenign hematologic and non-hematologic diseases. There are different outcomes of HSCT, as...
4.
Zolfaghari M, Barzegar M, Amiri V, Farsani M, Jesri S, Kiani Harchegani A, et al.
J Cosmet Laser Ther . 2019 Dec; 22(1):31-37. PMID: 31838924
Androgenic alopecia (AGA), as the most common cause of hair loss, is a chronic process that affects 80% of men and 50% of women throughout life. Existing and approved treatments...
5.
Karami A, Hamzeloo-Moghadam M, Yami A, Barzegar M, Mashati P, Gharehbaghian A
Nutr Cancer . 2019 Sep; 72(6):1043-1056. PMID: 31544515
Gaillardin (GLN) is a sesquiterpene lactone isolated from the chloroform extract of L. This natural compound has shown cytotoxicity in various cancerous cell line. However, its effect on leukemic cells...
6.
Rafiee M, Keramati M, Ayatollahi H, Sadeghian M, Barzegar M, Asgharzadeh A, et al.
Cell J . 2016 Aug; 18(2):159-64. PMID: 27540520
Objective: Signaling pathways such as extracellular regulated kinase/mitogen activated protein kinase (ERK/MAPK) have increased activity in leukemia. Ribosomal 6 kinase (RSK4) is a factor downstream of the MAPK/ERK pathway and...